Chronic Liver Disease Pipeline Insights Report, 2024: Development Stages, Key Players, Drug Mechanisms, Strategic Collaborations, and More
May 22, 2024 09:17 ET
|
Research and Markets
Dublin, May 22, 2024 (GLOBE NEWSWIRE) -- The "Chronic Liver Disease - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This report outlays comprehensive...
Liver Diseases Therapeutics Market to surpass US$ 24921.3 Million globally by end of 2027 - Coherent Market Insights
May 15, 2020 09:22 ET
|
CMI
SEATTLE, May 15, 2020 (GLOBE NEWSWIRE) -- Anti-rejection drugs/immunosupressants, anti-viral drugs, immunoglobulins, chemotherapy drugs, targeted therapies, vaccines are used in the treatment of...
Liver Diseases Therapeutics Market Growth To Be Driven By Extensive R&D Practices By Industry Players Till 2022: Grand View Research, Inc.
March 03, 2016 05:30 ET
|
Grand View Research
San Francisco, March 03, 2016 (GLOBE NEWSWIRE) -- The liver diseases therapeutics market had value over USD 7,498.0 million in 2014. The major driving factors are increasing numbers of liver...